DUBLIN–(BUSINESS WIRE)–The “Cancer Biological Therapy Market Research Report by Product (Cancer Growth Blockers, Monoclonal Antibodies, and Vaccines), Distribution Channel, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The United States Cancer Biological Therapy Market size was estimated at USD 10.65 billion in 2021, USD 12.46 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.38% to reach USD 22.63 billion by 2027.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cancer Biological Therapy Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Companies Mentioned
- AbbVie, Inc
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca PLC
- Bausch Health Companies Inc.
- Bayer AG
- Bristol-Myers Squibb
- Celgene Corporation
- Eisai Co., Ltd.
- Eli Lilly and Company
- EnGeneIC Ltd
- F. Hoffmann-La Roche AG
- GlaxoSmithKline PLC
- Hikma Pharmaceuticals PLC
- Incyte Corp
- Johnson & Johnson Services, Inc,
- Merck & Co., Inc.
- Novartis International AG
- Otsuka Pharmaceutical Co., Ltd
- Pfizer, Inc
- Sanofi SA
- Spectrum Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the United States Cancer Biological Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Cancer Biological Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Cancer Biological Therapy Market?
4. What is the competitive strategic window for opportunities in the United States Cancer Biological Therapy Market?
5. What are the technology trends and regulatory frameworks in the United States Cancer Biological Therapy Market?
6. What is the market share of the leading vendors in the United States Cancer Biological Therapy Market?
7. What modes and strategic moves are considered suitable for entering the United States Cancer Biological Therapy Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Cancer Biological Therapy Market, by Product
6.1. Introduction
6.2. Cancer Growth Blockers
6.3. Monoclonal Antibodies
6.4. Vaccines
7. Cancer Biological Therapy Market, by Distribution Channel
7.1. Introduction
7.2. Hospital
7.3. Retail & Mail Order Pharmacies
8. California Cancer Biological Therapy Market
9. Florida Cancer Biological Therapy Market
10. Illinois Cancer Biological Therapy Market
11. New York Cancer Biological Therapy Market
12. Ohio Cancer Biological Therapy Market
13. Pennsylvania Cancer Biological Therapy Market
14. Texas Cancer Biological Therapy Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
17. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/dcqghf
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900